| Original language | English |
|---|---|
| Pages (from-to) | 2183-2184 |
| Number of pages | 2 |
| Journal | The New England journal of medicine |
| Volume | 374 |
| Issue number | 22 |
| DOIs | |
| Publication status | Published - 2 Jun 2016 |
| Externally published | Yes |
Fingerprint
Homeodomain Proteins
Tumor Biomarkers
Antineoplastic Agents
Colonic Neoplasms
Gene Expression
ASJC Scopus subject areas
- Medicine(all)
Cite this
Chiche, L., Rinchai, D., & Chaussabel, D. J. (2016). CDX2 as a Prognostic Biomarker in Colon Cancer. The New England journal of medicine, 374(22), 2183-2184. https://doi.org/10.1056/NEJMc1602584#SA3
CDX2 as a Prognostic Biomarker in Colon Cancer. / Chiche, Laurent; Rinchai, Darawan; Chaussabel, Damien J.
In: The New England journal of medicine, Vol. 374, No. 22, 02.06.2016, p. 2183-2184.Research output: Contribution to journal › Letter
Chiche, L, Rinchai, D & Chaussabel, DJ 2016, 'CDX2 as a Prognostic Biomarker in Colon Cancer', The New England journal of medicine, vol. 374, no. 22, pp. 2183-2184. https://doi.org/10.1056/NEJMc1602584#SA3
Chiche L, Rinchai D, Chaussabel DJ. CDX2 as a Prognostic Biomarker in Colon Cancer. The New England journal of medicine. 2016 Jun 2;374(22):2183-2184. https://doi.org/10.1056/NEJMc1602584#SA3
@article{86fffe7847b84974879dc17ce36d85f3,
title = "CDX2 as a Prognostic Biomarker in Colon Cancer",
author = "Laurent Chiche and Darawan Rinchai and Chaussabel, {Damien J.}",
year = "2016",
month = "6",
day = "2",
doi = "10.1056/NEJMc1602584#SA3",
language = "English",
volume = "374",
pages = "2183--2184",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "22",
}
TY - JOUR
T1 - CDX2 as a Prognostic Biomarker in Colon Cancer
AU - Chiche, Laurent
AU - Rinchai, Darawan
AU - Chaussabel, Damien J.
PY - 2016/6/2
Y1 - 2016/6/2
UR - http://www.scopus.com/inward/record.url?scp=84979829014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979829014&partnerID=8YFLogxK
U2 - 10.1056/NEJMc1602584#SA3
DO - 10.1056/NEJMc1602584#SA3
M3 - Letter
VL - 374
SP - 2183
EP - 2184
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 22
ER -